Form 4: American Well Director Stephen Schlegel Receives Significant Equity Grant

American Well Corporation Director Stephen J. Schlegel was granted 27,855 restricted stock units (RSUs) of Class A Common Stock, aligning his interests with shareholders.

Summary

• Stephen J. Schlegel, a Director of American Well Corporation (AMWL), was granted 27,855 shares of Class A Common Stock in the form of restricted stock units (RSUs).
• The transaction date for this grant was June 11, 2025.
• The RSUs were granted at a price of $0 per share, which is typical for equity compensation.
• Following this transaction, Mr. Schlegel beneficially owns 64,303 shares of Class A Common Stock.
• The RSUs are subject to vesting, which occurs on the earlier of (i) the day immediately preceding the date of the first annual meeting of stockholders following the grant date, or (ii) the first anniversary of the grant date.

Sentiment

Score: 6

Explanation: The filing reports a routine equity compensation grant to a director, which is a neutral to slightly positive event as it aligns management interests with shareholders, but does not indicate significant operational or financial news.

Positives

• The grant of restricted stock units to Director Stephen J. Schlegel aligns his financial interests with those of the company's shareholders, incentivizing long-term performance.
• Equity compensation is a standard practice for retaining and motivating key personnel and board members.

Negatives

• No specific negative aspects are indicated by this routine equity compensation filing.

Risks

• This Form 4 filing, being a transaction report, does not detail specific company risks.

Future Outlook

The granted restricted stock units are subject to a vesting schedule, which will occur on the earlier of the day immediately preceding the first annual meeting of stockholders following the grant date or the first anniversary of the grant date, indicating future equity ownership for the director.

Industry Context

The grant of restricted stock units to a director is a common practice in the technology and healthcare sectors, including the telehealth industry where American Well operates. Such equity compensation is widely used to attract, retain, and incentivize board members and executives, aligning their long-term interests with company performance and shareholder value.

Comparison to Industry Standards

• Equity grants, such as restricted stock units, to non-employee directors are a standard component of compensation packages across publicly traded companies, particularly in growth-oriented sectors like healthcare technology.
• While specific comparable companies or projects are not detailed in this filing, the practice aligns with general market benchmarks for director compensation aimed at fostering long-term commitment and performance alignment.

Corporate Governance

Related Party Transactions

• The grant of restricted stock units to Stephen J. Schlegel, a director, constitutes a related party transaction, which is a standard form of compensation for board members.

Stakeholder Impact

• Shareholders: The grant aligns the director's interests with shareholders, potentially leading to better long-term decision-making focused on share price appreciation.
• Employees: No direct impact on general employees is indicated by this specific filing.

Next Steps

• Vesting of the 27,855 restricted stock units according to the specified schedule.

Key Dates

Keywords

American Well Corporation, AMWL, SEC Form 4, Restricted Stock Units, RSU Grant, Director Compensation, Insider Transaction, Equity Compensation, Corporate Governance